These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 3227806
1. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Graus F, Segurado OG, Tolosa E. Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806 [Abstract] [Full Text] [Related]
2. [Paraneoplastic cerebellar degeneration]. Nakano R, Sato S. Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701 [Abstract] [Full Text] [Related]
3. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB. Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700 [Abstract] [Full Text] [Related]
5. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964 [Abstract] [Full Text] [Related]
6. Paraneoplastic cerebellar degeneration: successful early detection and treatment of cancer through characterization of the anti-Purkinje cell antibody. Tanaka K, Igarashi S, Yamazaki M, Nakajima T, Miyatake T, Sakai K. Intern Med; 1992 Dec; 31(12):1339-42. PubMed ID: 1300168 [Abstract] [Full Text] [Related]
7. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB. N Engl J Med; 1990 Jun 28; 322(26):1844-51. PubMed ID: 2348838 [Abstract] [Full Text] [Related]
8. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Tanaka M, Tanaka K, Onodera O, Tsuji S. Clin Neurol Neurosurg; 1995 Feb 28; 97(1):95-100. PubMed ID: 7788981 [Abstract] [Full Text] [Related]
9. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Jaeckle KA, Graus F, Houghton A, Cardon-Cardo C, Nielsen SL, Posner JB. Ann Neurol; 1985 Nov 28; 18(5):592-600. PubMed ID: 2416270 [Abstract] [Full Text] [Related]
10. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. Smith JL, Finley JC, Lennon VA. J Neuroimmunol; 1988 Apr 28; 18(1):37-48. PubMed ID: 3346369 [Abstract] [Full Text] [Related]
11. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. J Neurol Sci; 1991 Nov 28; 106(1):82-7. PubMed ID: 1779243 [Abstract] [Full Text] [Related]
12. Ovarian carcinoma and paraneoplastic cerebellar degeneration. McLellan R, Currie JL, Royal W, Rosenshein NB. Obstet Gynecol; 1988 Dec 28; 72(6):922-5. PubMed ID: 3186102 [Abstract] [Full Text] [Related]
13. Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration. Tsukamoto T, Yoshie O, Tada K, Iwasaki Y. Arch Neurol; 1987 Aug 28; 44(8):833-7. PubMed ID: 3307712 [Abstract] [Full Text] [Related]
14. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration. Sindic CJ, Andersson M, Boucquey D, Chalon MP, Bisteau M, Brucher JM, Laterre EC. Acta Neurol Belg; 1993 Aug 28; 93(2):65-77. PubMed ID: 8506746 [Abstract] [Full Text] [Related]
15. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Cunningham J, Graus F, Anderson N, Posner JB. Neurology; 1986 Sep 28; 36(9):1163-8. PubMed ID: 3528917 [Abstract] [Full Text] [Related]
16. Cerebellar ataxia as a paraneoplastic syndrome. Dropcho EJ, Whitaker JN. Hosp Pract (Off Ed); 1989 Jan 30; 24(1A):69-79, 83-4. PubMed ID: 2536377 [No Abstract] [Full Text] [Related]
17. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody]. Tremouilhac C, Hamy A, De Ferron E, Paineau J, Visset J. J Gynecol Obstet Biol Reprod (Paris); 1996 Jan 30; 25(3):253-6. PubMed ID: 8767221 [Abstract] [Full Text] [Related]
18. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG. PLoS One; 2015 Jan 30; 10(4):e0123446. PubMed ID: 25885452 [Abstract] [Full Text] [Related]
19. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA. Mayo Clin Proc; 1990 Dec 30; 65(12):1558-63. PubMed ID: 2255217 [Abstract] [Full Text] [Related]
20. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Greenlee JE, Brashear HR. Ann Neurol; 1983 Dec 30; 14(6):609-13. PubMed ID: 6360029 [Abstract] [Full Text] [Related] Page: [Next] [New Search]